BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15800348)

  • 1. Overestimation of lung cancer mortality in a computed tomography-screened population.
    Grannis FW
    J Clin Oncol; 2005 Apr; 23(10):2439-40; author reply 2440-1. PubMed ID: 15800348
    [No Abstract]   [Full Text] [Related]  

  • 2. Tar-nished reputations.
    Lancet Oncol; 2008 May; 9(5):401. PubMed ID: 18452846
    [No Abstract]   [Full Text] [Related]  

  • 3. Computed tomography screening for lung cancer in a high-risk population: update on current status.
    Russo P; Paleari L; Granone P; Cesario A; Pastorino U
    J Natl Cancer Inst; 2008 Jul; 100(14):1043-4. PubMed ID: 18612133
    [No Abstract]   [Full Text] [Related]  

  • 4. Lung cancer screening trial financed by tobacco-funded foundation, sparks debate.
    Twombly R
    J Natl Cancer Inst; 2008 May; 100(10):690-1. PubMed ID: 18477793
    [No Abstract]   [Full Text] [Related]  

  • 5. Estimate of lung cancer mortality from low-dose spiral computed tomography screening trials: implications for current mass screening recommendations.
    Patz EF; Swensen SJ; Herndon JE
    J Clin Oncol; 2004 Jun; 22(11):2202-6. PubMed ID: 15169809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of screening for lung cancer.
    Chirikos TN; Hazelton T; Tockman M; Clark R
    JAMA; 2003 May; 289(18):2358; author reply 2358-9. PubMed ID: 12746351
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness of screening for lung cancer.
    Reich J
    JAMA; 2003 May; 289(18):2357; author reply 2358-9. PubMed ID: 12746349
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of screening for lung cancer.
    Petty TL
    JAMA; 2003 May; 289(18):2357; author reply 2358-9. PubMed ID: 12746350
    [No Abstract]   [Full Text] [Related]  

  • 9. A defence of the New York Early Lung Cancer Project.
    Henschke CI
    Lancet; 2003 Mar; 361(9363):1138. PubMed ID: 12672353
    [No Abstract]   [Full Text] [Related]  

  • 10. [More cases discovered, but mortality not reduced. What is the value of CT screening in bronchial carcinoma?].
    MMW Fortschr Med; 2011 Jan; 153(4):16. PubMed ID: 22165608
    [No Abstract]   [Full Text] [Related]  

  • 11. Limitations of screening for lung cancer with low-dose spiral computed tomography.
    Jett JR
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):4988s-4992s. PubMed ID: 16000601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobacco money: up in smoke?
    Mulshine JL; Smith RA; Field JK; Hirsch FR
    Lancet; 2002 Dec; 360(9349):1979-80; author reply 1981. PubMed ID: 12493299
    [No Abstract]   [Full Text] [Related]  

  • 13. Helical computed tomography has a role in the screening of lung cancer--the con argument.
    Davidson W
    Can Respir J; 2004 Apr; 11(3):217-8. PubMed ID: 15124041
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical integrity up in smoke? Conflicts of interest and the lung cancer screening controversy.
    Moy B
    Oncologist; 2008 May; 13(5):474-6. PubMed ID: 18515732
    [No Abstract]   [Full Text] [Related]  

  • 15. Lung cancer screening: an update.
    Marcus PM
    J Clin Oncol; 2001 Sep; 19(18 Suppl):83S-86S. PubMed ID: 11560979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
    Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is screening for lung cancer using low dose spiral CT scanning worthwhile?
    Gleeson FV
    Thorax; 2006 Jan; 61(1):5-7. PubMed ID: 16396951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-slice/helical computed tomography for lung cancer screening.
    Banerjee S
    Issues Emerg Health Technol; 2003 Jun; (48):1-4. PubMed ID: 12812212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential conflict of interest.
    Grannis FW
    Lung Cancer; 2002 Oct; 38(1):103-4; discussion 105. PubMed ID: 12367803
    [No Abstract]   [Full Text] [Related]  

  • 20. Improbable estimate of lung cancer mortality from screening trials.
    Tockman MS
    J Clin Oncol; 2005 Mar; 23(9):2106-7; author reply 2107-8. PubMed ID: 15774802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.